US drug markers respond to clinical trial claims
The accusations levelled at GlaxoSmithKline and Forest Laboratories that negative trial results on their products have been buried has prompted the US industry to set out its own code of practice.
Archives for July 4, 2004
Coating helps keep clinical trials 'blind'
Boehringer Ingelheim has been granted a US patent on a way to disguise real and placebo tablets in a clinical trial - without having to resort to placing them in larger capsules which may be difficult for patients to swallow.
New temp-tracking RFID label from KSW
German radio frequency identification technology company KSW Microtec is gearing up to launch a new RFID label for tracking supply chain integrity for pharmaceuticals, blood bags and perishable foods.
Venture capital: cash, not counsel?
A new survey has revealed that venture capital investment in health care ventures rarely goes beyond the money bestowed, and claims that VCs add value through their expertise are rarely if ever fulfilled.
Private equity firm buys Kemira fine chemicals
Finnish chemicals group Kemira has agreed to sell off its fine chemicals business to a private equity firm, exiting from what it sees as a non-core sector, reports Phil Taylor.
Novartis sets up TB, dengue centre
With the incidence of drug resistant tuberculosis (TB) and dengue fever rapidly accelerating worldwide, Novartis has announced the opening of a non-profit initiative in drug discovery focussing on advanced biomedical research for these diseases and...